BAX vs BMRN · rev $5.66B vs P/E 40, rev $1.76B
Baxter International Inc (BAX) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Baxter International Inc (BAX) is a medical instruments & supplies company listed on NYSE.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported BAX revenue for 2026-06-30 was $5.66B. Net income was $111.0M. BAX currently screens at market cap $10.01B.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
BAX currently screens at market cap $10.01B. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the BAX and BMRN stock pages for the full models.
Not investment advice.